BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 11121624)

  • 1. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management.
    Smith TE; Lee D; Turner BC; Carter D; Haffty BG
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1281-9. PubMed ID: 11121624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ipsilateral in-breast tumor relapse after breast conservation therapy: true recurrence versus new primary tumor.
    Abd-Alla HM; Lotayef MM; Abou Bakr A; Moneer MM
    J Egypt Natl Canc Inst; 2006 Sep; 18(3):183-90. PubMed ID: 17671527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. True recurrence versus new primary: an analysis of ipsilateral breast tumor recurrences after breast-conserving therapy.
    Panet-Raymond V; Truong PT; McDonald RE; Alexander C; Ross L; Ryhorchuk A; Watson PH
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):409-17. PubMed ID: 21288654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Tanaka-Akashi S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Breast Cancer; 2005; 12(2):104-11. PubMed ID: 15858440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.
    Huang E; Buchholz TA; Meric F; Krishnamurthy S; Mirza NQ; Ames FC; Feig BW; Kuerer HM; Ross MI; Singletary SE; McNeese MD; Strom EA; Hunt KK
    Cancer; 2002 Nov; 95(10):2059-67. PubMed ID: 12412158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.
    Yi M; Buchholz TA; Meric-Bernstam F; Bedrosian I; Hwang RF; Ross MI; Kuerer HM; Luo S; Gonzalez-Angulo AM; Buzdar AU; Symmans WF; Feig BW; Lucci A; Huang EH; Hunt KK
    Ann Surg; 2011 Mar; 253(3):572-9. PubMed ID: 21209588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ipsilateral in-breast tumor recurrence after breast conserving therapy: true recurrence versus new primary tumor.
    Alexandrova E; Sergieva S; Kostova P; Mihaylova I; Katzarov D; Milev A
    J BUON; 2015; 20(4):1001-8. PubMed ID: 26416048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local recurrence versus new primary: clinical analysis of 82 breast relapses and potential applications for genetic fingerprinting.
    Haffty BG; Carter D; Flynn SD; Fischer DB; Brash DE; Simons J; Ziegler AM; Fischer JJ
    Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):575-83. PubMed ID: 8226151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: new primary cancer allows a good prognosis.
    Nishimura S; Takahashi K; Akiyama F; Oguchi M; Tada K; Makita M; Iwase T; Yoshimoto M; Yamashita T; Sakamoto G; Kasumi F
    Breast Cancer; 2005; 12(2):112-7. PubMed ID: 15858441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second invasive breast cancers in patients treated with breast-conserving therapy.
    Wang J; Tang H; Yin K; Li X; Xie X; Hughes KS
    Eur J Surg Oncol; 2021 Oct; 47(10):2492-2498. PubMed ID: 34134902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse.
    Haffty BG; Reiss M; Beinfield M; Fischer D; Ward B; McKhann C
    J Clin Oncol; 1996 Jan; 14(1):52-7. PubMed ID: 8558220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in temporal patterns of local failure after breast-conserving therapy and their prognostic implications.
    Krauss DJ; Kestin LL; Mitchell C; Martinez AA; Vicini FA
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):731-40. PubMed ID: 15465189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ipsilateral breast tumor relapse: local recurrence versus new primary tumor and the effect of whole-breast radiotherapy on the rate of new primaries.
    Gujral DM; Sumo G; Owen JR; Ashton A; Bliss JM; Haviland J; Yarnold JR
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):19-25. PubMed ID: 20471183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment.
    Yoshida T; Takei H; Kurosumi M; Ninomiya J; Ishikawa Y; Hayashi Y; Tozuka K; Oba H; Kawanowa K; Inoue K; Tabei T
    Breast J; 2010; 16(2):127-33. PubMed ID: 20030655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation.
    Alpert TE; Kuerer HM; Arthur DW; Lannin DR; Haffty BG
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):845-51. PubMed ID: 16199315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-up.
    Kunkler IH; Kerr GR; Thomas JS; Jack WJ; Bartlett JM; Pedersen HC; Cameron DA; Dixon JM; Chetty U;
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):829-38. PubMed ID: 22197227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of XRCC4 expression by breast cancer cells on ipsilateral recurrence after breast-conserving therapy.
    Kitagawa M; Someya M; Hasegawa T; Mikami T; Asaishi K; Hasegawa T; Matsumoto Y; Kutomi G; Takemasa I; Sakata KI
    Strahlenther Onkol; 2019 Jul; 195(7):648-658. PubMed ID: 30997540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical characteristics and prognosis of patients with ipsilateral breast tumor recurrence after breast conservation therapy].
    Sun GY; Wang SL; Tang Y; Jin J; Song YW; Liu YP; Wang WH; Fang H; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):352-358. PubMed ID: 29860762
    [No Abstract]   [Full Text] [Related]  

  • 20. Four types of ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: classification of IBTR based on precise pathological examination.
    Sakai T; Nishimura S; Ogiya A; Tanabe M; Kimura K; Morizono H; Iijima K; Miyagi Y; Makita M; Ito Y; Oguchi M; Horii R; Akiyama F; Iwase T
    Pathol Int; 2015 Mar; 65(3):113-8. PubMed ID: 25600703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.